Safety and Pharmacokinetics of Once-Daily Regimens of Soft-Gel Capsule Saquinavir plus Minidose Ritonavir in Human Immunodeficiency Virus-Negative Adults

Human immunodeficiency virus type 1 (HIV-1) protease inhibitors have dramatically improved treatment options for HIV infection, but frequent dosing may impact adherence to highly active antiretroviral treatment regimens (HAART). Previous studies demonstrated that combined therapy with ritonavir and...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Kilby, J. Michael, Sfakianos, Greg, Gizzi, Nick, Siemon-Hryczyk, Peggy, Ehrensing, Eric, Oo, Charles, Buss, Neil, Saag, Michael S.
Format: Artigo
Idioma:Inglês
Publicat: American Society for Microbiology 2000
Matèries:
Pharmacology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC90133/
https://ncbi.nlm.nih.gov/pubmed/10991842
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars